MIG
HQL

Mariner Investment Group’s abrdn Life Sciences Investors HQL Stock Holding History

Mariner Investment Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-110,993
Closed -$1.93M – 65
2019
Q4 		$1.93M Buy
+110,993
New +$1.82M 2.17% 10

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Mariner Investment Group's HQL Position: Q1 2020 in Review

Mariner Investment Group sold out of abrdn Life Sciences Investors (HQL) in Q1 2020, closing a stake of 110,993 shares — an estimated $1.93M sold.

Mariner Investment Group first reported a position in HQL in Q4 2019 and held it in 1 quarter. The position peaked at $1.93M in Q4 2019. 69 funds tracked by Wall St. Rank hold HQL as of Q1 2020.

  • Mariner Investment Group reported no remaining abrdn Life Sciences Investors position as of Q1 2020 after selling out during the quarter.
  • Mariner Investment Group sold 110,993 abrdn Life Sciences Investors shares in Q1 2020, an estimated $1.93M.
  • Mariner Investment Group first reported a position in abrdn Life Sciences Investors in Q4 2019 and held it in 1 quarter.
  • Mariner Investment Group's abrdn Life Sciences Investors position peaked at $1.93M in Q4 2019.
  • 69 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2020.

Based on Mariner Investment Group's 13F filing for Q1 2020, filed 15 May 2020.